(Q33487354)

English

Use of liquid chromatography-tandem mass spectrometry for the quantitative and qualitative analysis of an antipsychotic agent and its metabolites in human plasma and urine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 July 2017

Use of liquid chromatography-tandem mass spectrometry for the quantitative and qualitative analysis of an antipsychotic agent and its metabolites in human plasma and urine (English)

1 reference

Europe PubMed Central

27 July 2017

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

author name string

Dear GJ

1

1 reference

Europe PubMed Central

27 July 2017

Fraser IJ

2

1 reference

Europe PubMed Central

27 July 2017

Patel DK

3

1 reference

Europe PubMed Central

27 July 2017

Long J

4

1 reference

Europe PubMed Central

27 July 2017

Pleasance S

5

1 reference

Europe PubMed Central

27 July 2017

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

27 July 2017

Journal of Chromatography

1 reference

Europe PubMed Central

27 July 2017

794

1 reference

Europe PubMed Central

27 July 2017

1-2

1 reference

Europe PubMed Central

27 July 2017

27-36

1 reference

Europe PubMed Central

27 July 2017

Positive vs. negative schizophrenia: a critical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2897%2900688-2

7 January 2021

The current status of the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2897%2900688-2

7 January 2021

Serotonin, schizophrenia and antipsychotic drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2897%2900688-2

7 January 2021

The evolution of the serotonin-dopamine antagonist concept

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2897%2900688-2

7 January 2021

The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2897%2900688-2

7 January 2021

Preclinical neurochemical and electrophysiological profile of 1192U90, a potential antipsychotic.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2897%2900688-2

7 January 2021

Is schizophrenia a neurological disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2897%2900688-2

7 January 2021

Depression in first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2897%2900688-2

7 January 2021

Identification of urinary and biliary conjugated metabolites of the neuromuscular blocker 51W89 by liquid chromatography/mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2897%2900688-2

7 January 2021

Identifiers

10.1016/S0021-9673(97)00688-2

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33487354&oldid=2144582832"